Nutriband (NASDAQ:NTRBW) Stock Price Up 1% – Should You Buy?

Nutriband Inc. (NASDAQ:NTRBWGet Free Report)’s share price traded up 1% on Monday . The stock traded as high as $0.50 and last traded at $0.5250. Approximately 1,683 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 2,164 shares. The stock had previously closed at $0.52.

Nutriband Stock Performance

The stock has a 50-day moving average of $1.03 and a two-hundred day moving average of $1.28.

Institutional Investors Weigh In On Nutriband

An institutional investor recently bought a new position in Nutriband stock. Empery Asset Management LP purchased a new position in Nutriband Inc. (NASDAQ:NTRBWFree Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises about 0.1% of Empery Asset Management LP’s investment portfolio, making the stock its 20th biggest holding.

About Nutriband

(Get Free Report)

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.

See Also

Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.